CureMatch, Inc. is a healthcare technology company based in San Diego, CA, specializing in precision medicine support for oncology. They leverage Knowledge Representation Reasoning (KRR) AI to provide innovative cancer treatment solutions, helping physicians rank the most promising systemic therapies for their patients and filter out therapies with poor outcomes. With access to 4.5 million expertly curated combinations of drugs, CureMatch enables healthcare professionals to compute their own drug choices alongside their data, utilizing the latest genomics data in their practice.
CureMatch collaborates with various stakeholders in the healthcare industry, including physicians, oncologists, tumor board coordinators, medical geneticists, investors, press and media, and collaborators. Their mission is to promote affordable and effective cancer treatment, and they have partnered with organizations like Mark Cuban Cost Plus Drug Company and CancerX to advance innovative cancer treatments. With a focus on precision medicine and personalized treatment plans, CureMatch is dedicated to improving outcomes for cancer patients.
Generated from the website